Intravenous versus subcutaneous immunoglobulin - Authors' reply. (Record no. 28288711)

MARC details
000 -LEADER
fixed length control field 00829 a2200229 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517211837.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201903s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1474-4465
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S1474-4422(18)30109-1
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name van Schaik, Ivo N
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190308
245 00 - TITLE STATEMENT
Title Intravenous versus subcutaneous immunoglobulin - Authors' reply.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Lancet. Neurology
Date of publication, distribution, etc. 05 2018
300 ## - PHYSICAL DESCRIPTION
Extent 393-394 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Letter; Comment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Intravenous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoglobulins, Intravenous
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mielke, Orell
773 0# - HOST ITEM ENTRY
Title The Lancet. Neurology
Related parts vol. 17
-- no. 5
-- p. 393-394
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S1474-4422(18)30109-1">https://doi.org/10.1016/S1474-4422(18)30109-1</a>
Public note Available from publisher's website

No items available.